###begin article-title 0
Lymphocytes and the Dap12 Adaptor Are Key Regulators of Osteoclast Activation Associated with Gonadal Failure
###end article-title 0
###begin p 1
Conceived and designed the experiments: PJ AA. Performed the experiments: AA. Analyzed the data: PJ AA MM. Contributed reagents/materials/analysis tools: RD. Wrote the paper: PJ AA.
###end p 1
###begin p 2
Current address: Aix Marseille Universite, Faculte des Sciences de Luminy, Centre d'Immunologie de Marseille-Luminy (CIML), Marseille, France; Inserm, U631, Marseille, France; CNRS, UMR6102, Marseille, France
###end p 2
###begin p 3
###xml 806 823 798 815 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro. In vivo</italic>
###xml 304 308 <span type="species:ncbi:10090">mice</span>
###xml 391 395 <span type="species:ncbi:10090">mice</span>
###xml 423 427 <span type="species:ncbi:10090">mice</span>
###xml 833 837 <span type="species:ncbi:10090">mice</span>
###xml 958 962 <span type="species:ncbi:10090">mice</span>
###xml 1002 1006 <span type="species:ncbi:10090">mice</span>
Bone resorption by osteoclasts is necessary to maintain bone homeostasis. Osteoclast differentiation from hematopoietic progenitors and their activation depend on M-CSF and RANKL, but also requires co-stimulatory signals acting through receptors associated with DAP12 and FcRgamma adaptors. Dap12 mutant mice (KDelta75) are osteopetrotic due to inactive osteoclasts but, surprisingly, these mice are more sensitive than WT mice to bone loss following an ovariectomy. Because estrogen withdrawal is known to disturb bone mass, at least in part, through lymphocyte interaction, we looked at the role of mature lymphocytes on osteoclastogenesis and bone mass in the absence of functional DAP12. Lymphocytes were found to stimulate an early osteoclast differentiation response from Dap12-deficient progenitors in vitro. In vivo, Rag1-/- mice lacking mature lymphocytes did not exhibit any bone phenotype, but lost their bone mass after ovariectomy like KDelta75 mice. KDelta75;Rag1-/- double mutant female mice exhibited a more severe osteopetrosis than Dap12-deficient animals but lost their bone mass after ovariectomy, like single mutants. These results suggest that both DAP12 and mature lymphocytes act synergistically to maintain bone mass under physiological conditions, while playing similar but not synergistic co-stimulatory roles in protecting bone loss after gonadal failure. Thus, our data support a role for lymphocytes during osteoclast differentiation and suggest that they may function as accessory cells when regular osteoclast function is compromised.
###end p 3
###begin title 4
Introduction
###end title 4
###begin p 5
###xml 634 637 634 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000585-Turner1">[1]</xref>
###xml 156 162 <span type="species:ncbi:9606">humans</span>
###xml 699 703 <span type="species:ncbi:10090">mice</span>
Bone remodeling and homeostasis result from the balanced activity of two cell types, osteoclasts for bone resorption and osteoblasts for bone formation. In humans, as well as in rodents, bone goes through different phases of development. During the growth phase, bone modeling takes place with a rate of formation higher than that of degradation. Once puberty occurs, the bone mass reaches a peak and subsequently remains constant through a balanced formation and degradation process. Finally, during aging, following gonadal failure and steroid hormone arrest, bone degradation takes over from bone formation leading to osteoporosis [1]. This aging process can be mimicked in animal models such as mice, by gonadectomy, leading to an inhibition of steroid hormone production and decreased bone mass.
###end p 5
###begin p 6
###xml 438 441 438 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000585-Carlsten1">[2]</xref>
###xml 812 815 812 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000585-Perry1">[3]</xref>
###xml 816 819 816 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000585-Thurmond1">[5]</xref>
###xml 1033 1036 1033 1036 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000585-Li1">[6]</xref>
###xml 1189 1192 1185 1188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000585-Cenci1">[7]</xref>
###xml 1194 1197 1190 1193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000585-Roggia1">[8]</xref>
###xml 1338 1341 1334 1337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000585-Lee1">[9]</xref>
###xml 1618 1622 1606 1610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000585-Takayanagi1">[10]</xref>
###xml 3 8 <span type="species:ncbi:9606">women</span>
In women, the major etiology of osteoporosis is estrogen withdrawal after menopause. Many different studies have been carried out in order to understand the mechanisms of estrogen activity on bone mass, and to generate new therapies to prevent or cure the disease. Despite this work, exactly how estrogens act on bone cells still remains unclear. Most of the estrogen activity on bone cannot be explained by a direct effect on bone cells [2]. Several lines of evidence indicate that disruption of the hormonal status through variations in estrogen levels acts on the hematopoietic compartment and especially on B and T lymphocyte precursors. An elevated estrogen level decreases B lymphopoiesis, whereas a decrease in estrogen levels, following ovariectomy, induces an accumulation of pre-B cells in bone marrow [3]-[5]. Moreover, in the last few years, many reports have emphasized the role played by T lymphocytes through cytokine release, in the control of bone mass under normal physiological conditions or after gonadal failure [6]. T cells have been shown to be one of the key activators of bone resorption via TNFalpha secretion, leading to osteoporosis in the absence of estrogens [7], [8]. However these data remain controversial as Lee et al. (2006) have recently suggested that T lymphocytes are not implicated in this process [9]. It is currently difficult to have a clear opinion on the precise role of lymphocytes in bone homeostasis, since lymphocytes secrete RANKL, TNFalpha, IL-1, IL-6, OPG or IFNgamma, which have all been shown to have either stimulatory or inhibitory effects on osteoclastogenesis [10].
###end p 6
###begin p 7
###xml 554 558 546 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000585-Turnbull1">[11]</xref>
###xml 926 930 918 922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000585-Cella1">[12]</xref>
###xml 932 936 924 928 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000585-Paloneva1">[13]</xref>
###xml 1124 1128 1112 1116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000585-Koga1">[14]</xref>
###xml 1129 1133 1117 1121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000585-Humphrey1">[17]</xref>
###xml 1216 1220 1204 1208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000585-Paloneva2">[18]</xref>
###xml 1222 1226 1210 1214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000585-Kaifu1">[19]</xref>
###xml 1379 1387 1367 1375 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1735 1739 1723 1727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000585-Koga1">[14]</xref>
###xml 1741 1745 1729 1733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000585-Nataf1">[16]</xref>
###xml 1747 1754 1735 1742 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
###xml 1818 1826 1806 1814 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1963 1970 1951 1958 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1975 1983 1963 1971 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 2495 2499 2471 2475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000585-Koga1">[14]</xref>
###xml 2903 2907 2867 2871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000585-Koga1">[14]</xref>
###xml 2909 2913 2873 2877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000585-Mocsai1">[15]</xref>
###xml 2915 2919 2879 2883 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000585-Faccio1">[20]</xref>
###xml 2921 2925 2885 2889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000585-Mao1">[21]</xref>
###xml 737 743 <span type="species:ncbi:9606">humans</span>
###xml 821 826 <span type="species:ncbi:9606">human</span>
###xml 1015 1019 <span type="species:ncbi:10090">mice</span>
###xml 1153 1159 <span type="species:ncbi:9606">humans</span>
###xml 1164 1168 <span type="species:ncbi:10090">mice</span>
###xml 1320 1327 <span type="species:ncbi:9606">patient</span>
###xml 1516 1520 <span type="species:ncbi:10090">mice</span>
###xml 1756 1762 <span type="species:ncbi:10090">murine</span>
###xml 1987 1993 <span type="species:ncbi:9606">humans</span>
###xml 2001 2005 <span type="species:ncbi:10090">mice</span>
###xml 2115 2119 <span type="species:ncbi:10090">mice</span>
###xml 2354 2358 <span type="species:ncbi:10090">mice</span>
###xml 2426 2430 <span type="species:ncbi:10090">mice</span>
###xml 2490 2494 <span type="species:ncbi:10090">mice</span>
Mature multinucleated osteoclasts are formed by the fusion of hematopoietic precursors of the myeloid/monocytic lineage. Although, signals driven by Receptor Activator of NF-kappaB Ligand (RANKL) and Macrophage-Colony-Stimulating Factor (M-CSF) are clearly essential for osteoclastogenesis, regulation by other receptor-mediated signals is less well defined. In addition, recent data have implicated co-stimulatory signals through DAP12 and FcRgamma molecular adaptors, which function in concert with many receptors such as TREM2 and OSCAR, respectively [11]. DAP12 (also called KARAP or TYROBP) is a small transmembrane polypeptide comprising a unique cytoplasmic ITAM signaling domain mediating all of its known effector functions. In humans, TREM2 or DAP12 deficiencies are responsible for Nasu-Hakola disease, a rare human disease, characterized at the bone level, by osteoporotic lesions at the extremities of long bones [12], [13]. In contrast, Dap12 complete deletion or Dap12 loss of function (KDelta75) in mice leads to osteopetrosis due to the presence in bones of numerous but inactive multinucleated osteoclasts [14]-[17]. Interestingly, in humans and mice, the bone phenotype appears just after puberty [18], [19] (our unpublished data). Unexpectedly, osteoclast differentiation and function of Nasu-Hakola patient-derived mononuclear myeloid precursors is impaired in vitro, similar to the severe block of osteoclast differentiation observed when bone or spleen myeloid precursors from Dap12-deficient mice are cultured in the presence of M-CSF and RANKL. However, co-cultures of Dap12-deficient hematopoietic precursors, together with M-CSF, RANKL and stromal cells or osteoblasts, can restore a weak osteoclastogenesis [14], [16]. In vivo, murine osteoclasts differentiate but function poorly whereas, in vitro, there is an early block of osteoclastogenesis as no multinucleated osteoclasts can be obtained. Differences between osteoclastogenesis in vivo and in vitro in humans and in mice, as well as co-culture experiments, suggest that other co-stimulatory signals are present in Dap12-deficient mice to allow osteoclast differentiation. Indeed, Koga et al. (2004) have demonstrated that FcRgamma, the other ITAM bearing adaptor protein expressed by osteoclasts, is critical for osteoclast differentiation. Although single FcRgamma-/- mice do not present any bone phenotype, Dap12;FcRgamma double knock-out mice exhibit a severe osteopetrosis compared to single Dap12-/- mice [14]. Therefore, in the absence of a functional DAP12 protein, FcRgamma mediates co-stimulatory signals that can restore a weak osteoclast differentiation. The binding of still unknown ligands to DAP12- and FcRgamma- associated receptors leads to the phosphorylation of their ITAM motif, which activates syk kinase and phopholipase Cgamma, resulting in the amplification of NFATc1, an osteoclast master gene [14], [15], [20], [21].
###end p 7
###begin p 8
###xml 242 246 <span type="species:ncbi:10090">mice</span>
###xml 372 376 <span type="species:ncbi:10090">mice</span>
###xml 503 507 <span type="species:ncbi:10090">mice</span>
###xml 607 611 <span type="species:ncbi:10090">mice</span>
###xml 747 751 <span type="species:ncbi:10090">mice</span>
Since Dap12 deficiency affects bone resorption after puberty and estrogens regulate the lymphoid cell compartment, we hypothesize that lymphocytes could act as a co-stimulatory signal to stimulate osteoclastogenesis in Dap12 loss of function mice. In this paper, we first show that gonadal failure is a permissive condition that triggers osteoclast resorption in KDelta75 mice. We then address the role played by mature lymphocytes in normal osteoclastogenesis and in bone physiology, analyzing Rag1-/- mice lacking mature B and T lymphocytes, concomitantly with KDelta75 and double mutant Rag1-/-;KDelta75 mice. We show that mature lymphocytes play a similar role to DAP12 in protecting against bone degradation after ovariectomy in female adult mice. Our data support a role for lymphocytes during osteoclastogenesis and suggest that they may function as accessory cells under certain conditions when regular osteoclast function is compromised.
###end p 8
###begin title 9
Results
###end title 9
###begin title 10
###xml 57 61 <span type="species:ncbi:10090">mice</span>
Ovariectomy activates bone resorption in Dap12-deficient mice
###end title 10
###begin p 11
###xml 413 422 409 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000585-g001">Figure 1A</xref>
###xml 549 558 545 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000585-g001">Figure 1B</xref>
###xml 748 764 740 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000585-g001">Figures 1A and C</xref>
###xml 1102 1111 1086 1095 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000585-g001">Figure 1D</xref>
###xml 1126 1127 1110 1111 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1243 1244 1223 1224 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1263 1264 1243 1244 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1340 1341 1320 1321 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1362 1363 1342 1343 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1380 1381 1360 1361 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1405 1406 1385 1386 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1500 1509 1476 1485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000585-g001">Figure 1E</xref>
###xml 1588 1589 1564 1565 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1842 1845 1814 1817 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000585-Carlsten1">[2]</xref>
###xml 1847 1851 1819 1823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000585-Masuzawa1">[22]</xref>
###xml 35 39 <span type="species:ncbi:10090">mice</span>
###xml 308 312 <span type="species:ncbi:10090">mice</span>
###xml 543 547 <span type="species:ncbi:10090">mice</span>
###xml 619 623 <span type="species:ncbi:10090">mice</span>
###xml 688 692 <span type="species:ncbi:10090">mice</span>
###xml 837 841 <span type="species:ncbi:10090">mice</span>
###xml 1066 1070 <span type="species:ncbi:10090">mice</span>
###xml 1217 1221 <span type="species:ncbi:10090">mice</span>
###xml 1457 1461 <span type="species:ncbi:10090">mice</span>
###xml 1640 1644 <span type="species:ncbi:10090">mice</span>
###xml 1767 1771 <span type="species:ncbi:10090">mice</span>
###xml 1837 1841 <span type="species:ncbi:10090">mice</span>
Since bone mass in Dap12-deficient mice increases due to the inability of osteoclasts to resorb bone after puberty, we wanted to check whether estrogen withdrawal after ovariectomy could reactivate bone resorption and thus restore the bone mass phenotype. For this purpose, 8-week-old KDelta75 and WT female mice were ovariectomized and sacrificed 4 weeks later and their long bones analyzed by histomorphometry (Figure 1A). Ovarian ablation was complete since uteral weight was significantly lower in ovariectomized compared to sham-operated mice (Figure 1B). Bone histomorphometrical analysis showed that the control mice lost 30% of bone mass one month after ovariectomy, but KDelta75 mice lost 45% of their bone mass under the same conditions (Figures 1A and C). This showed that bone resorption, which is impaired in KDelta75 adult mice, can be restored after ovariectomy. Because ovariectomy is known to disturb lymphocyte population homeostasis in the bone marrow we also analyzed the hematopoietic cell distribution in the bone marrow and spleen of KDelta75 mice after ovariectomy. As shown on Figure 1D, only the B220+ B lymphocyte number doubled in the bone marrow after ovariectomy in both WT and KDelta75 mice. The numbers of CD11b+ monocytes, and Gr1+ granulocytes were not modified. In contrast, in spleen, the numbers of B220+ B lymphocytes, CD11b+ monocytes, CD11c+ dendritic cells and Gr1+ granulocytes were similar in both KDelta75 and WT mice and were not modified by ovariectomy (Figure 1E). It should be noted that CD11c dendritic cells in bone marrow, as well as CD3+ T lymphocytes in spleen had increased in KDelta75 mice but not in response to ovariectomy. This increase in B cell lymphocytes in the bone marrow of ovariectomized female adult mice is in agreement with published data for wild type ovariectomized mice [2], [22]. This prompted us to analyze further the role played by mature lymphocytes on Dap12-deficient osteoclast progenitors.
###end p 11
###begin title 12
###xml 24 28 <span type="species:ncbi:10090">mice</span>
Ovariectomy of KDelta75 mice triggers bone mass reduction.
###end title 12
###begin p 13
###xml 62 66 <span type="species:ncbi:10090">mice</span>
###xml 372 376 <span type="species:ncbi:10090">mice</span>
###xml 435 439 <span type="species:ncbi:10090">mice</span>
Ovariectomy (ovx) was performed on 8-week-old WT and KDelta75 mice. 4 weeks later, ovariectomized and sham operated animals were sacrificed. (A) Histomorphometric analysis was performed on long bones after Von Kossa/Von Gieson staining. (B) Efficiency of ovariectomy was assessed by weighing uteri. (C) Bone mass was quantified. Results of the quantification show that WT mice lost 30% of bone mass after ovariectomy, whereas KDelta75 mice lost around 45%. (D and E) Hematopoietic populations from bone marrow (D) or spleen (E) were characterized by flow cytometry using the B220 antibody for B lymphocytes; CD11b for monocytes; CD11c for dendritic cells; Gr1 for granulocytes and CD3 for T lymphocytes. (* p<0.01, ** p<0.001, *** p<0.0001)
###end p 13
###begin title 14
Mature lymphocytes enhance osteoclast differentiation of Dap12-deficient progenitors
###end title 14
###begin p 15
###xml 90 98 90 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 289 297 289 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 611 640 607 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000585-g002">Figures 2A left panels and 2B</xref>
###xml 1138 1155 1130 1147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000585-g002">Figures 2A and 2B</xref>
###xml 43 48 <span type="species:ncbi:10090">mouse</span>
###xml 380 384 <span type="species:ncbi:10090">mice</span>
###xml 516 521 <span type="species:ncbi:10090">mouse</span>
###xml 725 730 <span type="species:ncbi:10090">mouse</span>
###xml 1273 1278 <span type="species:ncbi:10090">mouse</span>
Osteoclasts are present in Dap12-deficient mouse bones but are poorly functional, whereas in vitro, they cannot be differentiated in the presence of MCSF and RANKL, the two osteoclastogenic cytokines. In order to analyze the role of lymphocytes in osteoclast differentiation, we performed in vitro osteoclast differentiation from spleen cells from Dap12 loss of function KDelta75 mice versus WT littermates. Leukocytes, in the presence or absence of lymphocytes, were plated in the presence of MCSF and RANKL. In WT mouse cells, osteoclast differentiation occurred independently of the presence of lymphocytes (Figures 2A left panels and 2B). As expected, after 7 days in culture, no osteoclasts differentiated from KDelta75 mouse leukocytes in the absence of lymphocytes. However, when lymphocytes were present in large amounts, we noticed a significant increase in TRAP activity, since 20% of cells in culture were TRAP+. Among these, multinucleated TRAP+ osteoclasts were identified, representing a third of the total number of multinucleated cells formed with WT precursors but containing, on average, 7 nuclei versus 20 in controls (Figures 2A and 2B). This lymphocyte mediated osteoclastogenic effect was not due to RANKL, since addition of soluble RANKL to KDelta75 mouse leukocytes in the absence of lymphocytes did not enhance osteoclast differentiation (data not shown). So, in addition to M-CSF and RANKL, and independently of RANKL concentration, lymphocytes partially restore osteoclast differentiation from Dap12-deficient hematopoietic precursor cells but have no stimulatory role on WT progenitors.
###end p 15
###begin title 16
###xml 69 74 <span type="species:ncbi:10090">mouse</span>
Lymphocytes enhance osteoclastogenesis from KDelta75 but not from WT mouse spleen cells.
###end title 16
###begin p 17
###xml 20 24 <span type="species:ncbi:10090">mice</span>
(A) WT and KDelta75 mice spleen cells were isolated using different lymphocyte separation media to collect osteoclast precursors without (upper panels) or with (lower panels) lymphocytes. Osteoclast differentiation was carried out in the presence of M-CSF and RANKL. Seven days later, cell cultures were fixed and stained for TRAP activity. Lymphocytes increased the formation of TRAP positive osteoclasts from KDelta75 spleen cells (KDelta75+Ly). Pictures of representative fields from several experiments. (B) Quantification under the different culture conditions, of the number of TRAP+ cells per dish; TRAP+ osteoclasts with more than 3 nuclei; average number of nuclei per multinucleated osteoclast. These figures are representative of three different experiments. (* p<0.01, ** p<0.001, *** or daggerdaggerdagger p<0.0001)
###end p 17
###begin title 18
Mature lymphocytes do not stimulate bone resorption activity of Dap12-deficient osteoclasts
###end title 18
###begin p 19
###xml 55 63 55 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 684 691 672 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 781 789 765 773 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 885 892 865 872 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 894 903 874 883 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000585-g003">Figure 3A</xref>
###xml 913 921 893 901 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1175 1184 1147 1156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000585-g003">Figure 3A</xref>
###xml 1521 1528 1489 1496 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1876 1885 1840 1849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000585-g003">Figure 3B</xref>
###xml 1973 1982 1937 1946 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000585-g003">Figure 3C</xref>
###xml 2191 2200 2151 2160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000585-g003">Figure 3D</xref>
###xml 2279 2288 2239 2248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000585-g003">Figure 3E</xref>
###xml 2571 2578 2527 2534 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 2627 2635 2579 2587 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 2666 2673 2618 2625 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 78 83 <span type="species:ncbi:10090">mouse</span>
###xml 456 460 <span type="species:ncbi:10090">mice</span>
###xml 718 723 <span type="species:ncbi:10090">mouse</span>
###xml 880 884 <span type="species:ncbi:10090">mice</span>
###xml 1813 1818 <span type="species:ncbi:10090">mouse</span>
###xml 2052 2057 <span type="species:ncbi:10090">mouse</span>
###xml 2457 2461 <span type="species:ncbi:10090">mice</span>
###xml 2590 2594 <span type="species:ncbi:10090">mice</span>
Small multinucleated osteoclasts can be differentiated in vitro from KDelta75 mouse splenocytes and TRAP activity is increased in the presence of lymphocytes. We then checked whether, in addition to osteoclastogenesis, lymphocytes also stimulate bone resorbing activity of the formed osteoclasts. We evaluated several markers typical of mature functional osteoclasts and compared these activities with those of osteoclasts present in the bones of KDelta75 mice. We first analyzed by RT-PCR the expression of an early differentiation marker (Cathepsin K), and a late differentiation marker (calcitonin receptor, CTR). RNA was extracted from WT and KDelta75 bones without bone marrow ("in vivo") and from WT or KDelta75 mouse spleen cell cultures, enriched or not with lymphocytes ("in vitro"). Both Cathepsin K and CTR were expressed at similar levels in bones from WT or KDelta75 mice in vivo (Figure 3A). During in vitro osteoclast differentiation, cathepsin K was expressed at low levels and CTR was not detected in KDelta75 cells compared to WT cells. However, in lymphocyte enriched cultures, cathepsin K and CTR were expressed by KDelta75 cells, as well as by WT cells (Figure 3A). From these results we can conclude that lymphocytes trigger the expression of differentiation markers of KDelta75 osteoclast precursors. Because the main function of osteoclasts is to resorb bone matrix, we then decided to examine whether or not such differentiated osteoclasts would be able to resorb apatite mineralized matrix like in vivo KDelta75 osteoclasts. For this purpose, we analyzed both their ability to form an actin containing sealing zone on calcium apatite and to resorb it. Functional tests for osteoclast activity were carried out on ACC (Apatite Collagen Complex) matrix. Osteoclasts differentiated from WT mouse cells formed a typical sealing zone on the ACC matrices (Figure 3B) and resorbed it, as resorption pits could be observed in the vicinity of osteoclasts (Figure 3C, white arrow). In contrast, osteoclasts differentiated from KDelta75 mouse spleen cells, enriched in lymphocytes and spread on ACC matrix did not form any sealing zone but only actin-containing lamellipodia (Figure 3D). These were not functional since they did not resorb the mineralized matrix (Figure 3E). This absence of resorption was also verified on dentine slices (not shown). So, in the presence of M-CSF and RANKL as well as lymphocytes, spleen cells from KDelta75 mice can differentiate into multinucleated osteoclasts but these are not functional similarly to what is observed in vivo inKDelta75 mice. Thus, by adding lymphocytes to in vitro cultures we can reproduce the in vivo osteoclast phenotype. During osteoclastogenesis, mature lymphocytes may act as accessory cells in the absence of a functional DAP12 protein.
###end p 19
###begin title 20
Lymphocytes trigger osteoclast marker expression but not bone resorption from KDelta75 hematopoietic precursors.
###end title 20
###begin p 21
###xml 146 154 142 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 287 294 279 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 318 325 310 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 419 427 407 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 520 528 508 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 118 123 <span type="species:ncbi:10090">mouse</span>
###xml 274 279 <span type="species:ncbi:10090">mouse</span>
###xml 392 397 <span type="species:ncbi:10090">mouse</span>
###xml 598 603 <span type="species:ncbi:10090">mouse</span>
###xml 749 754 <span type="species:ncbi:10090">mouse</span>
Expression of cathepsin K (Cath K) and calcitonin (CTR) receptors by RT-PCR. RNAs were extracted from WT and KDelta75 mouse spleen cell cultures (in vitro) maintained for 7 days with MCSF and RANKL, with or without (+Ly) lymphocytes. As a control, RNAs from WT and KDelta75 mouse bones (in vivo) were also used. Under in vivo conditions, both Cath K and CTR were expressed in WT and KDelta75 mouse bones, as well as in in vitro cultures from corresponding spleen cell cultures. However, in the absence of lymphocytes in in vitro cultures, Cath K is weakly expressed and CTR is absent from KDelta75 mouse cell cultures. (B-E) Functional resorption tests on mineralized ACC matrix. Osteoclasts were differentiated in Petri dishes from WT and KDelta75 mouse spleen cells in the presence of lymphocytes, and then removed before being plated on ACC matrix. After 24h, cell cultures were fixed and stained with phalloidin (B, D) and their resorption ability was evaluated by the formation of pits (C, D). WT osteoclasts on ACC matrix exhibited a typical actin-containing sealing zone associated with resorption (B, C white arrow). In contrast, actin from KDelta75 derived osteoclasts did not form a sealing zone but was mostly arranged in lamellipodia (D) and these did not resorb apatite (E).
###end p 21
###begin title 22
Absence of mature lymphocytes increases bone mass only in the absence of a functional DAP12 protein
###end title 22
###begin p 23
###xml 51 59 51 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 240 244 240 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000585-Mombaerts1">[23]</xref>
###xml 465 472 457 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000585.s001">Data S1</xref>
###xml 542 557 534 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000585-g004">Figure 4A and B</xref>
###xml 983 992 967 976 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000585-g004">Figure 4A</xref>
###xml 994 1001 978 985 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000585-t001">Table 1</xref>
###xml 1349 1358 1333 1342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000585-g004">Figure 4B</xref>
###xml 1503 1512 1487 1496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000585-g004">Figure 4C</xref>
###xml 1693 1702 1673 1682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000585-g004">Figure 4D</xref>
###xml 1948 1955 1928 1935 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000585-t001">Table 1</xref>
###xml 183 188 <span type="species:ncbi:10090">mouse</span>
###xml 327 331 <span type="species:ncbi:10090">mice</span>
###xml 418 422 <span type="species:ncbi:10090">mice</span>
###xml 591 595 <span type="species:ncbi:10090">mice</span>
###xml 762 766 <span type="species:ncbi:10090">mice</span>
###xml 828 832 <span type="species:ncbi:10090">mice</span>
###xml 873 877 <span type="species:ncbi:10090">mice</span>
###xml 971 975 <span type="species:ncbi:10090">mice</span>
###xml 1029 1033 <span type="species:ncbi:10090">mice</span>
###xml 1451 1455 <span type="species:ncbi:10090">mice</span>
###xml 1562 1566 <span type="species:ncbi:10090">mice</span>
###xml 1652 1656 <span type="species:ncbi:10090">mice</span>
###xml 1687 1691 <span type="species:ncbi:10090">mice</span>
###xml 1804 1808 <span type="species:ncbi:10090">mice</span>
As lymphocytes compensate for Dap12 deficiency for in vitro osteoclastogenesis, we decided to evaluate the importance of lymphocytes in the control of bone mass. We chose the Rag1-/- mouse model deficient in both mature T and B lymphocytes [23]. We generated Rag1-/- or KDelta75 as well as Rag1-/-;KDelta75 (DKO) double mutant mice with identical genetic backgrounds. The bone parameters (BV/TV) of 12-week-old female mice were analyzed first with a micro scanner (Data S1) and also, for confirmation, by histomorphometry on calcified bones (Figure 4A and B). We first observed that Rag1-/- mice did not present any particular bone phenotype in comparison to WT animals of a similar genotype. This genetic approach allowed us to confirm once again that KDelta75 mice had an increased bone mass (21%) compared with WT or Rag1-/- mice. More importantly, we observed that DKO mice had an even higher increased bone mass to compare with KDelta75 (30%) and control or Rag1-/- mice (60%) (Figure 4A, Table 1). In comparison with other mice, trabeculae thickness was unchanged in the DKO animals. In addition, the number of trabaculae had increased, whereas the space between them was reduced. This phenotype is mostly due to impairment of osteoclast function, since the number of osteoclasts counted on bone surfaces was similar for all four backgrounds (Figure 4B), while collagen type I degradation products present in the urine of 12-week-old DKO female mice had decreased by 17% compared with WT females (Figure 4C). This was further confirmed in 6-month-old male mice in which collagen type I degradation products had decreased in both KDelta75 and DKO mice, compared with WT and Rag1-/- mice (Figure 4D). These data demonstrate that the absence of mature B and T lymphocytes does not affect bone mass in mice with a normal genetic background but acts synergistically with a Dap12 deficiency to increase bone mass by inhibiting osteoclast activity (Table 1).
###end p 23
###begin title 24
###xml 30 37 30 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 87 91 <span type="species:ncbi:10090">mice</span>
Absence of mature lymphocytes in vivo enhances the osteopetrosis phenotype in KDelta75 mice through inhibition of osteoclast function.
###end title 24
###begin p 25
###xml 706 707 682 683 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 9 13 <span type="species:ncbi:10090">mice</span>
###xml 42 46 <span type="species:ncbi:10090">mice</span>
###xml 116 120 <span type="species:ncbi:10090">mice</span>
###xml 193 197 <span type="species:ncbi:10090">mice</span>
###xml 420 424 <span type="species:ncbi:10090">mice</span>
###xml 485 489 <span type="species:ncbi:10090">mice</span>
###xml 499 503 <span type="species:ncbi:10090">mice</span>
###xml 573 577 <span type="species:ncbi:10090">mice</span>
###xml 623 627 <span type="species:ncbi:10090">mice</span>
###xml 692 696 <span type="species:ncbi:10090">mice</span>
KDelta75 mice were crossbred with Rag1-/- mice devoid of mature lymphocytes. The bone phenotype of KDelta75;Rag1-/- mice (called DKO), as well as control littermates (DWT, Rag1-/- and KDelta75 mice), was quantified by histomorphometric analysis. (A) Bone mass was assessed after Von Kossa/Von Gieson staining; trabeculae numbers, thickness and space between trabeculae were quantified using specific softwares. KDelta75 mice have a mild but significant osteopetrosis compared with DWT mice. Rag1-/- mice did not exhibit any bone phenotype whereas osteopetrosis in KDelta75 mice increased in the absence of lymphocytes (DKO mice) and was statistically significant, compared to DWT or KDelta75 mice. (B) TRAP+ osteoclast numbers per bone surface unit were assessed directly on bone slices. No statistical differences were observed between animals of the four different genotypes. (D and E) Deoxypyridinoline cross-link degradation products were measured in evening urines and expressed as a ratio with creatinine in 3-month-old females (C) and 6-month-old males (D). (*or dagger p<0.01, ** p<0.001, *** p<0.0001)
###end p 25
###begin title 26
###xml 78 82 <span type="species:ncbi:10090">mice</span>
Summary of bone mass phenotype in normal or ovariectomized 3-month-old female mice according to genotype
###end title 26
###begin title 27
Mature lymphocytes are not implicated in bone loss after ovariectomy
###end title 27
###begin p 28
###xml 389 398 389 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000585-g005">Figure 5A</xref>
###xml 531 540 531 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000585-g005">Figure 5B</xref>
###xml 693 702 693 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000585-g005">Figure 5C</xref>
###xml 750 759 750 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000585-g001">Figure 1C</xref>
###xml 871 878 871 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000585-t001">Table 1</xref>
###xml 981 990 981 990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000585-g005">Figure 5C</xref>
###xml 1057 1066 1053 1062 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000585-g001">Figure 1C</xref>
###xml 1242 1249 1238 1245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000585.s002">Data S2</xref>
###xml 1559 1566 1555 1562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000585-t001">Table 1</xref>
###xml 274 278 <span type="species:ncbi:10090">mice</span>
###xml 645 649 <span type="species:ncbi:10090">mice</span>
###xml 744 748 <span type="species:ncbi:10090">mice</span>
###xml 895 899 <span type="species:ncbi:10090">mice</span>
###xml 1051 1055 <span type="species:ncbi:10090">mice</span>
###xml 1283 1287 <span type="species:ncbi:10090">mice</span>
###xml 1361 1365 <span type="species:ncbi:10090">mice</span>
As DAP12 activity protects against bone loss after ovariectomy and lymphocytes seem to play a similar accessory role, we wanted to know whether Dap12 deletion would act independently or synergistically with mature lymphocyte depletion. Eight-week-old Rag1-/- and DKO female mice were ovariectomized or sham operated, and one month later were sacrificed for bone histomorphometry analysis (Figure 5A). The uteri of sacrificed sham operated and ovariectomized animals were weighed to ensure that the ovariectomy had been successful (Figure 5B). BV/TV evaluated by microscanner imaging (not shown) and histomorphometry analysis showed that Rag1-/- mice had lost more than 50% of their bone mass (Figure 5C) compared with the 30% lost by WT female mice (Figure 1C), suggesting that mature lymphocytes play an important role in protecting against bone loss after gonadectomy (Table 1). Double mutant mice deficient in both Dap12 and mature lymphocytes also lost 50% of their bone mass (Figure 5C), compared with 45% bone loss after ovariectomy of KDelta75 mice (Figure 1C). In summary, it is possible to compare levels of bone loss after ovariectomy in the absence of mature lymphocytes and in the presence or absence of functional DAP12 protein (Data S2). Strikingly, although WT female mice lost 30% of bone mass after ovariectomy, the bone loss was 45 to 50% for mice lacking lymphocytes in the presence or absence of a functional Dap12 gene. In addition, the protective effects of DAP12 and lymphocytes on bone mass loss after ovariectomy were not cumulative (Table 1).
###end p 28
###begin title 29
Mature lymphocytes and DAP12 protect against gonadal failure induced bone loss.
###end title 29
###begin p 30
###xml 59 63 <span type="species:ncbi:10090">mice</span>
###xml 363 367 <span type="species:ncbi:10090">mice</span>
###xml 397 401 <span type="species:ncbi:10090">mice</span>
Ovariectomies were performed on 8-week-old Rag1-/- and DKO mice. Four weeks later, both ovariectomized and sham operated animals were sacrificed. (A) Bone mass was assessed by histomorphometric analysis after Von Kossa/Von Gieson staining. (B) The efficiency of ovariectomy was evaluated by weighing the uteri. (C) Results of the quantification show that Rag1-/- mice, as well as KDelta75;Rag1-/- mice, lost more than 50% of their bone mass after ovariectomy. (*** or daggerdaggerdagger p<0.0001)
###end p 30
###begin title 31
Discussion
###end title 31
###begin p 32
###xml 1235 1242 1219 1226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000585-t001">Table 1</xref>
###xml 166 170 <span type="species:ncbi:10090">mice</span>
###xml 416 420 <span type="species:ncbi:10090">mice</span>
###xml 536 540 <span type="species:ncbi:10090">mice</span>
###xml 594 598 <span type="species:ncbi:10090">mice</span>
###xml 833 837 <span type="species:ncbi:10090">mice</span>
###xml 1011 1015 <span type="species:ncbi:10090">mice</span>
###xml 1138 1142 <span type="species:ncbi:10090">mice</span>
DAP12 is a molecular adaptor for transmembrane receptors of unknown ligands, which signals through an ITAM domain. It is required for normal bone homeostasis because mice with impaired DAP12 function, either by targeted inactivation of the ITAM domain or through its complete deletion, develop osteopetrosis after puberty due to the inability of osteoclasts to resorb bone. In this study, using Dap12 ITAM-deficient mice (KDelta75), we expanded on these previous data by showing unexpectedly that bone resorption in mutant adult female mice is restored after ovariectomy. KDelta75 adult female mice were much more sensitive to ovariectomy than WT littermates. Looking for potential cofactors that could act together with DAP12, to maintain bone homeostasis during adult life, we turned our interest toward lymphocytes. Adult Rag1-/- mice, which do not produce any mature B and T lymphocytes, do not present any bone phenotype but suffer a massive decrease in bone mass after ovariectomy. However, double mutant mice with an inactivated DAP12 protein in the absence of mature lymphocytes had increased osteopetrosis compared with KDelta75 mice and their bone mass was decreased to the same extent as KDelta75 animals after ovariectomy (Table 1).
###end p 32
###begin p 33
###xml 180 183 180 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000585-Li1">[6]</xref>
###xml 185 189 185 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000585-Weitzmann1">[24]</xref>
###xml 284 288 284 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000585-Cenci2">[25]</xref>
###xml 332 335 332 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000585-Lee1">[9]</xref>
###xml 993 997 985 989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000585-Takayanagi2">[26]</xref>
###xml 999 1003 991 995 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000585-Gao1">[27]</xref>
###xml 1164 1168 1156 1160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000585-Masuzawa1">[22]</xref>
###xml 1170 1174 1162 1166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000585-Miyaura1">[28]</xref>
###xml 2370 2374 2362 2366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000585-Sato1">[29]</xref>
###xml 1247 1251 <span type="species:ncbi:10090">mice</span>
###xml 1754 1758 <span type="species:ncbi:10090">mice</span>
Increasing evidence suggests that immune and skeletal systems share a number of regulatory molecules, but the role played by lymphocytes in bone homeostasis is still controversial [6], [24]. It has been proposed that T lymphocytes are important players in postmenopausal osteoporosis [25] but opposing data have also been published [9]. T lymphocytes could act directly or indirectly on bone cells and mostly on osteoclasts through the secretion of various cytokines. However, even this is difficult to reconcile since T lymphocytes have been reported to secrete cytokines with osteoclastogenic activities such as RANKL, TNFalpha, IL1, IL6 or antiosteoclastogenic factors such as OPG. The effects of T cells on osteoclastogenesis should depend on the balance between the positive and negative factors that they express. For example, T cell-produced IFNgamma which has been reported to inhibit osteoclastogenesis directly but to stimulate it indirectly through antigen-driven T cell activation [26], [27]. On the other hand, the role played by B lymphocytes is mostly recognized through the observation that B lymphopoiesis is stimulated during estrogen deficiency [22], [28]. We reconfirmed this although only in the bone marrow of ovariectomized mice and not in spleen. It is therefore extremely difficult to reconcile all these contradictory data, which could also depend on the genetic background of animals studied. It is also possible to propose that the co-stimulatory pathways involved in osteoclastogenesis could play different, or even opposite roles in specific anatomical bone microenvironments as Wu et al. have shown for ITAM-bearing coadaptors [Wu et al., 2007, PLOSone]. In this work we show that in the specific context of Rag1-deficient mice, mature B and T lymphocytes do not play any role in normal adult bone homeostasis but overall bone mass is drastically reduced after ovariectomy. We cannot rule out the possibility that T and B lymphocytes play opposite roles, which are then nullified in the absence of the two populations. To decipher the role played by lymphocytes in bone homeostasis the specific role of lymphocyte subpopulations will have to be addressed. Indeed, a recent report by Sato et al. has shown the specific importance of the T helper 17 (Th17) subpopulation through secretion of IL17 in bone destruction in rheumatoid arthritis [29].
###end p 33
###begin p 34
###xml 564 571 564 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000585.s002">Data S2</xref>
###xml 650 658 650 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 663 670 663 670 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 689 697 689 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 882 886 882 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000585-Mocsai1">[15]</xref>
###xml 888 892 888 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000585-Nataf1">[16]</xref>
###xml 894 898 894 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000585-Kaifu1">[19]</xref>
###xml 935 942 935 942 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 200 204 <span type="species:ncbi:10090">mice</span>
###xml 253 257 <span type="species:ncbi:10090">mice</span>
###xml 994 998 <span type="species:ncbi:10090">mice</span>
The protective effect of DAP12 on ovariectomy-induced bone loss has been emphasized since we show here that bone resorption activity can be restored after ovariectomy of Dap12 loss of function mutant mice. Similar results have been obtained with female mice in which Dap12 has been completely deleted [Wu et al., 2007, PLOSone]. In the physiopathological context of gonadal failure, DAP12 impairment and lymphocyte depletion do not act synergistically since bone mass reduction after ovariectomy is the same when either one or both of these factors are disturbed (Data S2). However, B and T lymphocytes can partially compensate for the lack of DAP12 in vitro and in vivo. Indeed, from our in vitro studies we have shown that lymphocytes enhance Dap12-deficient osteoclast precursor differentiation but do not activate their bone resorbing activity like osteoblasts or stromal cells [15], [16], [19]. This supports the observation that in vivo, the inhibition of osteoclast activity in KDelta75 mice is more drastic in the absence of lymphocytes, leading to a more severe osteopetrosis, reinforcing the hypothesis that lymphocytes are somehow implicated in the control of bone mass reduction in relation to Dap12 deficiency.
###end p 34
###begin p 35
###xml 156 160 152 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000585-Koga1">[14]</xref>
###xml 162 166 158 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000585-Mocsai1">[15]</xref>
###xml 168 172 164 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000585-Baron1">[30]</xref>
###xml 216 223 212 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
From our results we can propose that lymphocytes play a similar role to the FcRgamma co-stimulatory pathway on osteoclastogenesis and bone mass homeostasis [14], [15], [30]. Indeed, the absence of mature lymphocytes in vivo mimics FcRgamma deficiency as far as bone mass homeostasis is concerned, according to data reported by Wu et al. (accompanying article). It is then possible to conclude that Dap12 and mature lymphocytes play similar roles in protecting bone mass in the specific context of gonadal failure.
###end p 35
###begin title 36
Materials and Methods
###end title 36
###begin title 37
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice
###end title 37
###begin p 38
###xml 85 89 81 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000585-Tomasello1">[31]</xref>
###xml 26 30 <span type="species:ncbi:10090">mice</span>
###xml 80 84 <span type="species:ncbi:10090">mice</span>
###xml 100 104 <span type="species:ncbi:10090">mice</span>
###xml 157 161 <span type="species:ncbi:10090">mice</span>
###xml 213 217 <span type="species:ncbi:10090">mice</span>
###xml 278 282 <span type="species:ncbi:10090">mice</span>
###xml 526 530 <span type="species:ncbi:10090">mice</span>
###xml 625 629 <span type="species:ncbi:10090">mice</span>
KDelta75 loss-of-function mice were derived from eight backcrosses with C57BL/6 mice [31]. KDelta75 mice and Rag1-/- (C57Bl/10) (Charles River Laboratories) mice were crossbred to obtain double heterozygotes. All mice used came from the crossbreeding of the double heterozygote mice. They were bred and kept under pathogen free conditions with sterilized food, water and bedding in the Plateau de Biologie Experimentale de la Souris (IFR128 Lyon Biosciences, Lyon, France). To induce sex hormone deficiency, 8-week-old female mice underwent transabdominal ovariectomies (OVX), whereas the controls consisted of sham-operated mice (SHAM). Surgery was performed under general anesthesia using a Xylasine (12 mg/kg, Sigma)/Ketamine hydrochloride (0.1 mg/kg, Centravet) mixture, following procedures in agreement with the ethical rules set by the IFR 128 animal facility committee.
###end p 38
###begin title 39
Cell cultures
###end title 39
###begin p 40
###xml 408 409 396 397 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 448 449 436 437 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 668 669 652 653 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 739 740 723 724 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1121 1125 1101 1105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000585-Destaing1">[32]</xref>
###xml 41 46 <span type="species:ncbi:10090">mouse</span>
###xml 639 643 <span type="species:ncbi:10090">mice</span>
###xml 705 710 <span type="species:ncbi:10090">mouse</span>
###xml 964 970 <span type="species:ncbi:10090">murine</span>
###xml 981 986 <span type="species:ncbi:9606">human</span>
###xml 1067 1082 <span type="species:ncbi:4922">Pichia pastoris</span>
###xml 1095 1100 <span type="species:ncbi:4932">yeast</span>
Leukocytes were isolated from 8-week-old mouse spleens. Spleens were dissociated in complete medium (alphaMEM (Life technologies), 10% serum (Biowest), 2 mM L-Glutamine, 100U/mL Penicillin, 100 microg/ml streptomycin (Invitrogen)), then filtered through a 100 microm cell strainer (Falcon). Two lymphocyte separation media with different densities were used to isolate leukocytes: Eurobio (density 1.077 g/cm3) and Lympholyte-M (density 1.0875 g/cm3; Cederlane) (The high density medium allowed lymphocytes to be excluded from nucleated spleen cells such as monocytes, NK cells or dendritic cells. Leukocytes isolated from WT and KDelta75 mice, plated at 2500 cells/mm2, or from Rag1-/- and double mutant mouse cells plated at 250 cells/mm2 were cultured in complete alphaMEM in the presence of M-CSF and RANKL. Osteoclast differentiation was evaluated by Tartrate Resistant Acid Phosphatase staining, using the Leucocyte Acid Phosphatase kit (Sigma). Recombinant murine M-CSF and human RANKL were produced in our laboratory using insect cells baculovirus system and Pichia pastoris recombinant yeast cells, respectively [32].
###end p 40
###begin p 41
###xml 293 297 293 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000585-Shibutani1">[33]</xref>
###xml 299 303 299 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000585-Saltel1">[34]</xref>
Apatite Collagen Complex (ACC) coverslips to test osteoclast resorption ability are composed of glass coverslips coated with type I collagen and mineralized by calcium apatite crystals, which can be resorbed by mature osteoclasts. They were prepared according to a method described previously [33], [34].
###end p 41
###begin title 42
Immunofluorescence
###end title 42
###begin p 43
Osteoclasts differentiated from spleen leucocytes in the presence of M-CSF and RANKL, were detached with PBS EDTA (0.25 mM) and plated on ACC slices overnight at 37degreesC. Cells were then fixed in 4% paraformaldehyde (pH 7.2) for 15min at 4degreesC and rinsed with PBS. They were then labeled with phalloidine-Alexa 546 and observed with a confocal microscope (model LSM510; Carl Zeiss MicroImaging, Inc.). Resorption pits were directly observed by phase contrast microscopy.
###end p 43
###begin title 44
Reverse Transcriptase and Polymerase Chain Reaction
###end title 44
###begin p 45
###xml 63 71 63 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
mRNA was extracted with RNAnow reagent (Biogentex) either from in vitro cell cultures, or directly from bones devoid of marrow, crushed in liquid nitrogen. Aliquots (1 microg) were reverse transcribed using the MuLV-RT kit (Promega). Polymerase chain reactions were performed with specific primers using the Taq polymerase kit (Eurobio). Oligonucleotides were designed as follows:
###end p 45
###begin p 46
-GAPDH 5'-CAAAGTGGAGATTGTTGCCAT-3'
###end p 46
###begin p 47
3'-CACCACCTTCTTGATGTCATC-5'
###end p 47
###begin p 48
-Cathepsin K 5'-TTAATTTGGGAGAAAAACCT-3'
###end p 48
###begin p 49
3'-AGCCGCCTCCACAGCCATAAT-5'
###end p 49
###begin p 50
-Calcitonin receptor 5'-TGGTGGAGGTTGTGCCCAATGGAGA-3'
###end p 50
###begin p 51
3'-CTCGTGGGTTTGCCTCATCTTGGTC-5'
###end p 51
###begin title 52
Bone Parameters and Histomorphometric Analysis
###end title 52
###begin p 53
###xml 415 419 401 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000585-Parfitt1">[35]</xref>
Bones were fixed in PBS plus 4% paraformaldehyde over night at 4degreesC and then stored in 70% ethanol. Femurs were scanned by high resolution micro-CT (microCT-20, Scanco Medical, Bassersdorf, Switzerland) with a cubic voxel size of 9 microm and the 3D structural parameters calculated. For histomorphometric analysis, calcified bones were fixed and embedded in methylmethacrylate according to standard protocols [35]. Seven microm thick methyl methacrylate sections were used for Von Gieson/Von Kossa staining as well as for TRAP/hematoxylin stainings. Bone cellular and macroscopic measurements were made using a microscope (model DMLB; Leica), a 3CCD color video DXC-390 camera (Sony) and the OsteoMeasure Analysis System (Osteometrics). Bone-related degradation products from type 1 collagen, deoxypyridinoline cross-links and creatinine were measured in evening urine using the Pyrilinks-D immunoassay and creatine kit (Quidel corporation, San Diego, CA), according to the manufacturer's protocols.
###end p 53
###begin p 54
###xml 129 130 129 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 51 55 <span type="species:ncbi:10090">mice</span>
Animal groups were composed of a minimum of 6 to 8 mice. Statistical differences between groups were assessed using the Students t test.
###end p 54
###begin title 55
Supporting Information
###end title 55
###begin p 56
###xml 185 193 181 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000585-g004">Figure 4</xref>
###xml 50 54 <span type="species:ncbi:10090">mice</span>
###xml 207 211 <span type="species:ncbi:10090">mice</span>
###xml 275 279 <span type="species:ncbi:10090">mice</span>
###xml 289 293 <span type="species:ncbi:10090">mice</span>
###xml 381 385 <span type="species:ncbi:10090">mice</span>
###xml 435 439 <span type="species:ncbi:10090">mice</span>
The bone phenotype of DKO, Rag1-/- and K Delta 75 mice and control littermates DWT was imaged (A) and quantified (B) by microscanner in order to confirm the histomorphometric analysis (Figure 4). K Delta 75 mice exhibited mild but significant osteopetrosis compared with DWT mice. Rag1-/- mice did not exhibit any significant bone phenotype whereas the osteopetrosis of K Delta 75 mice had increased in the absence of lymphocytes (DKO mice). (* p<0.01, ** p<0.001)
###end p 56
###begin p 57
(2.43 MB TIF)
###end p 57
###begin p 58
Click here for additional data file.
###end p 58
###begin p 59
###xml 69 73 <span type="species:ncbi:10090">mice</span>
Percentage of bone mass loss after ovariectomy in 3-month-old female mice of identical genetic background.
###end p 59
###begin p 60
(0.22 MB TIF)
###end p 60
###begin p 61
Click here for additional data file.
###end p 61
###begin p 62
We thank Luc Malaval and Animage for help with microscanner analysis.
###end p 62
###begin title 63
References
###end title 63
###begin article-title 64
Skeletal effects of estrogen.
###end article-title 64
###begin article-title 65
Immune responses and bone loss: the estrogen connection.
###end article-title 65
###begin article-title 66
###xml 33 39 <span type="species:ncbi:10090">murine</span>
Effects of high-dose estrogen on murine hematopoietic bone marrow precede those on osteogenesis.
###end article-title 66
###begin article-title 67
###xml 117 121 <span type="species:ncbi:10090">mice</span>
Comparative effects of estrogen and raloxifene on B lymphopoiesis and bone loss induced by sex steroid deficiency in mice.
###end article-title 67
###begin article-title 68
###xml 111 116 <span type="species:ncbi:10090">mouse</span>
Role of estrogen receptor alpha in hematopoietic stem cell development and B lymphocyte maturation in the male mouse.
###end article-title 68
###begin article-title 69
B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo.
###end article-title 69
###begin article-title 70
Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha.
###end article-title 70
###begin article-title 71
Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo.
###end article-title 71
###begin article-title 72
###xml 23 27 <span type="species:ncbi:10090">mice</span>
T lymphocyte-deficient mice lose trabecular bone mass with ovariectomy.
###end article-title 72
###begin article-title 73
Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems.
###end article-title 73
###begin article-title 74
Activating and inhibitory functions of DAP12.
###end article-title 74
###begin article-title 75
Impaired differentiation of osteoclasts in TREM-2-deficient individuals.
###end article-title 75
###begin article-title 76
DAP12/TREM2 deficiency results in impaired osteoclast differentiation and osteoporotic features.
###end article-title 76
###begin article-title 77
Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis.
###end article-title 77
###begin article-title 78
The immunomodulatory adapter proteins DAP12 and Fc receptor gamma-chain (FcRgamma) regulate development of functional osteoclasts through the Syk tyrosine kinase.
###end article-title 78
###begin article-title 79
###xml 54 58 <span type="species:ncbi:10090">mice</span>
Brain and bone damage in KARAP/DAP12 loss-of-function mice correlate with alterations in microglia and osteoclast lineages.
###end article-title 79
###begin article-title 80
The signaling adapter protein DAP12 regulates multinucleation during osteoclast development.
###end article-title 80
###begin article-title 81
Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts.
###end article-title 81
###begin article-title 82
###xml 88 92 <span type="species:ncbi:10090">mice</span>
Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice.
###end article-title 82
###begin article-title 83
High dose M-CSF partially rescues the Dap12-/- osteoclast phenotype.
###end article-title 83
###begin article-title 84
PLCgamma2 regulates osteoclastogenesis via its interaction with ITAM proteins and GAB2.
###end article-title 84
###begin article-title 85
###xml 50 55 <span type="species:ncbi:10090">mouse</span>
Estrogen deficiency stimulates B lymphopoiesis in mouse bone marrow.
###end article-title 85
###begin article-title 86
###xml 16 20 <span type="species:ncbi:10090">mice</span>
RAG-1-deficient mice have no mature B and T lymphocytes.
###end article-title 86
###begin article-title 87
Estrogen deficiency and bone loss: an inflammatory tale.
###end article-title 87
###begin article-title 88
Estrogen deficiency induces bone loss by increasing T cell proliferation and lifespan through IFN-gamma-induced class II transactivator.
###end article-title 88
###begin article-title 89
T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma.
###end article-title 89
###begin article-title 90
IFN-gamma stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation.
###end article-title 90
###begin article-title 91
###xml 64 68 <span type="species:ncbi:10090">mice</span>
Increased B-lymphopoiesis by interleukin 7 induces bone loss in mice with intact ovarian function: similarity to estrogen deficiency.
###end article-title 91
###begin article-title 92
Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction.
###end article-title 92
###begin article-title 93
Arming the osteoclast.
###end article-title 93
###begin article-title 94
###xml 109 113 <span type="species:ncbi:10090">mice</span>
Combined natural killer cell and dendritic cell functional deficiency in KARAP/DAP12 loss-of-function mutant mice.
###end article-title 94
###begin article-title 95
Podosomes display actin turnover and dynamic self-organization in osteoclasts expressing actin-green fluorescent protein.
###end article-title 95
###begin article-title 96
Use of glass slides coated with apatite-collagen complexes for measurement of osteoclastic resorption activity.
###end article-title 96
###begin article-title 97
Apatite-mediated actin dynamics in resorbing osteoclasts.
###end article-title 97
###begin article-title 98
Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee.
###end article-title 98
###begin p 99
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 99
###begin p 100
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by grants from the Agence Nationale pour la Recherche, ANR maladies rares; Fondation pour la Recherche Medicale (FRM), and ProA program from INSERM. A. Anginot was a recipient of a PhD grant from the French Ministry of Research and from the Association pour la Recherche contre le Cancer (ARC); R. Dacquin has been a recipient of an ARC fellowship and is currently recipient of INSERM fellowship.
###end p 100

